Miller Anestesia

271. Witte CL, Witte MH: Splanchnic circulatory and

tissue fluid dynamics in portal hypertension. Fed

Proc 42:1685, 1983.

272. Ebrahimkhani MR, Mani AR, Moore K: Hydrogen

sulphide and the hyperdynamic circulation in cirr-

hosis: A hypothesis. Gut 54:1668, 2005.

273. Schrier RW,AbrahamWT: Hormones and hemody-

namics in heart failure. N Engl J Med 341:577,

1999.

274. Garcia-Estan J, Ortiz MC, Lee SS: Nitric oxide and

renal and cardiac dysfunction in cirrhosis. Clin Sci

102:213, 2002.

275. Heneghan MA, Harrison PM: Pathogenesis of

ascites in cirrhosis and portal hypertension. Med

Sci Monit 6:807, 2000.

276. Levy M, Wexler MJ: Renal sodium retention and

ascites formation in dogs with experimental cirrho-

sis but without portal hypertension or increased

splanchnic vascular capacity.J Lab Clin Med 91:520,

1978.

277. Kullak-Ublick GA, Meier PJ: Mechanisms of cho-

lestasis. Clin Liver Dis 4:357, 2000.

278. Strazzabosco M: Transport systems in cholangio-

cytes: Their role in bile formation and cholestasis.

Yale J Biol Med 70:427, 1997.

279. Velayudham LS, Farrell GC: Drug-induced choles-

tasis. Expert Opin Drug Saf 2:287, 2003.

280. Levy C, Lindor KD: Drug-induced cholestasis. Clin

Liver Dis 7:311, 2003.

281. Tung BY, Carithers RL Jr: Cholestasis and alcoholic

liver disease. Clin Liver Dis 3:585, 1999.

282. Mullally BA, Hansen WF: Intrahepatic cholestasis

of pregnancy: Review of the literature. Obstet

Gynecol Surv 57:47, 2002.

283. Reyes H,Sjovall J: Bile acids and progesterone meta-

bolites in intrahepatic cholestasis of pregnancy.Ann

Med 32:94, 2000.

284. Trauner M, Fickert P, Stauber RE: Inflammation-

induced cholestasis. J Gastroenterol Hepatol 14:946,

1999.

285. Gilroy RK,Mailliard ME,Gollan JL: Gastrointestinal

disorders of the critically ill. Cholestasis of sepsis.

Best Pract Res Clin Gastroenterol 17:357, 2003.

286. Hirata K, Ikeda S, Honma T, et al: Sepsis and cho-

lestasis: Basic findings in the sinusoid and bile cana-

liculus. J Hepatobiliary Pancreat Surg 8:20, 2001.

287. Moseley RH: Sepsis and cholestasis. Clin Liver Dis

3:465, 1999.

288. Sandhu IS, Jarvis C, Everson GT: Total parenteral

nutrition and cholestasis. Clin Liver Dis 3:489,

1999.

289. Teitelbaum DH, Tracy T: Parenteral nutrition–asso-

ciated cholestasis. Semin Pediatr Surg 10:72, 2001.

290. Jansen PL: The pathophysiology of cholestasis with

special reference to primary biliary cirrhosis. Best

Pract Res Clin Gastroenterol 14:571, 2000.

291. Casali AM, Carbone G, Cavalli G: Intrahepatic bile

duct loss in primary sclerosing cholangitis: A quan-

titative study. Histopathology 32:449, 1998.

292. Luketic VA, Shiffman ML: Benign recurrent intra-

hepatic cholestasis. Clin Liver Dis 3:509, 1999.

293. Trauner M, Fickert P, Stauber RE: Hepatocellular

bile salt transport: Lessons from cholestasis. Can J

Gastroenterol 14:99D, 2000.

294. Jansen PL, Muller M: Genetic cholestasis: Lessons

from the molecular physiology of bile formation.

Can J Gastroenterol 14:233, 2000.

295. Thompson R, Strautnieks S: BSEP: Function and

role in progressive familial intrahepatic cholestasis.

Semin Liver Dis 21:545, 2001.

296. Shaffer EA: Cholestasis: The ABCs of cellular

mechanisms for impaired bile secretion—transpor-

ters and genes. Can J Gastroenterol 16:380, 2002.

297. Carulli N, Manenti F, Ponz de Leon M, et al: Alte-

ration of drug metabolism during cholestasis in

man. Eur J Clin Invest 5:455, 1975.

298. Richter E, Breimer DD, Zilly W: Disposition of

hexobarbital in intra- and extrahepatic cholestasis

in man and the influence of drug metabolism–in-

ducing agents. Eur J Clin Pharmacol 17:197, 1980.

299. Miguet JP, Vuitton D, Deschamps JP, et al: Choles-

tasis and hepatic drug metabolism. Comparison of

metabolic clearance rate of antipyrine in patients

with intrahepatic or extrahepatic cholestasis. Dig

Dis Sci 26:718, 1981.

300. Kawata S, Imai Y, Inada M, et al: Selective reduction

of hepatic cytochrome P450 content in patients

with intrahepatic cholestasis. A mechanism for

impairment of microsomal drug oxidation. Gas-

troenterology 92:299, 1987.

301. Chen J, Farrell GC: Bile acids produce a generalized

reduction of the catalytic activity of cytochromes

P450 and other hepatic microsomal enzymes in

vitro: Relevance to drug metabolism in experimental

cholestasis. J Gastroenterol Hepatol 11:870, 1996.

302. Basso D, Fabris C, Plebani M, et al: Alterations in

bilirubin metabolism during extra- and intrahepa-

tic cholestasis. Clin Invest 70:49, 1992.

303. Glasova H, Beuers U: Extrahepatic manifestations

of cholestasis. J Gastroenterol Hepatol 17:938,

2002.

304. Berk PD, Javitt NB: Hyperbilirubinemia and choles-

tasis. Am J Med 64:311, 1978.

305. Binah O,Rubinstein I,BomzonA,et al: Effects of bile

acids on ventricular muscle contraction and electro-

physiological properties: Studies in rat papillary

muscle and isolated ventricular myocytes. Naunyn

Schmiedebergs Arch Pharmacol 335:160, 1987.

306. Jacob G, Nassar N, Hayam G, et al: Cardiac function

and responsiveness to beta-adrenoceptor agonists

in rats with obstructive jaundice. Am J Physiol

265:G314, 1993.

307. Bomzon A, Monies-Chass I, Kamenetz L, et al:

Anesthesia and pressor responsiveness in chronic

bile-duct–ligated dogs. Hepatology 11:551, 1990.

308. Tamakuma S, Wada N, Ishiyama M, et al: Relation-

ship between hepatic hemodynamics and biliary

pressure in dogs: Its significance in clinical shock

following biliary decompression. Jpn J Surg 5:255,

1975.

206

Fisiología y anestesia